Home > Insider Trading > Filing (0000919574-18-004871)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1634432	Strongbridge Biopharma Plc	SBBP	()	4

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1325713	Bruce Kovner	C/O Caxton Corporation 731 Alexander Road, Building #2 Princeton NJ 08540	No	No	Yes	No
1388551	Caxton Corp	731 Alexander Road Building #2 Princeton NJ 08540	No	No	Yes	No
1576081	Cdk Associates, L.l.c.	C/O Caxton Corporation 731 Alexander Road, Building #2 Princeton NJ 08540	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Ordinary Shares, $0.01 Par Value	Acquisiton	2018-07-19	14,000	$4.98	5,423,234	No	4	P	Direct
Ordinary Shares, $0.01 Par Value	Acquisiton	2018-07-20	21,100	$4.97	5,444,334	No	4	P	Direct
Ordinary Shares, $0.01 Par Value	Acquisiton	2018-07-23	20,400	$4.95	5,464,734	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Footnotes

These shares represent (a) 5,169,133 Ordinary Shares that are owned directly by CDK Associates, LLC, which is a reporting person, and may be deemed to be indirectly beneficially owned by (i) Caxton Corporation, the manager of CDK Associates, LLC, and (ii) Bruce Kovner, the chairman and sole shareholder of Caxton Corporation; and (b) 295,601 Ordinary Shares beneficially owned by employees of an affiliate of Caxton Corporation and may be deemed to be indirectly beneficially owned by (i) Caxton Corporation and (ii) Bruce Kovner, the chairman and sole shareholder of Caxton Corporation. Each Reporting Person disclaims beneficial ownership in the securities reported on this Form 4 except to the extent of its or his pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.